Global Pathological Examination Market

Pathological Examination Comprehensive Study by Type (Traditional Pathology, Digital Pathology), Application (Digestive Organs, Other), Testing Services (Anatomic Pathology, Surgical Pathology, Cytopathology, Clinical Pathology) Players and Region - Global Market Outlook to 2030

Pathological Examination Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The pathology examination is a complex process which involves many people and many steps. It is difficult for the evaluation of infection, neoplasm, or genetic abnormalities. The valuable information generated by the pathology examination is used by many physician to best determine the course of health care. Furthermore, the pathology examination is a key part in determining the presence or absence of cancer. The pathological examination provides information on how best to treat the cancer if it is present. According to AMA Research, the market for Pathological Examination is expected to register a CAGR of 9.8% during the forecast period to 2030. This growth is primarily driven by Increase in Prevalence of Several Infectious Diseases Worldwide .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Quest Diagnostics, Inc. (United States), Sonic Healthcare Limited (Australia), Spectra Laboratories (United States), Diagnostic Pathology Services, Inc. (United States), Q2 Solutions (United States), Histo-Scientific Research Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (United States), Thermo Fisher Scientific, Inc. (United States) and Laboratory Corporation of America Holdings (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In February 2024, Roche Diagnostics partnered with PathAI to create AI digital pathology algorithms for Roche's companion diagnostics sector, aiming to advance precision medicine.
In March 2022, Roche collaborated with Bristol Myers Squibb to advance personalized healthcare via digital pathology solutions. The collaboration included supporting the advancement of two assays for use in clinical trials.The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies.

Influencing Trend:
Increasing Focus on Early Diagnosis of Diseases

Market Growth Drivers:
Increase in Prevalence of Several Infectious Diseases Worldwide, Rise in Incidence of Chronic Diseases and Surge in Geriatric Population and Rise in Health Awareness

Challenges:
Absence of Reimbursement Policies

Restraints:
Dearth of Pathologists

Opportunities:
Usage of Digital Pathology in Disease Diagnosis

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Pathological Examination Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Pathological Examination Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Pathological Examination players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Pathological Examination Study Sheds Light on
— The Pathological Examination Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Pathological Examination industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Pathological Examination industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Traditional Pathology
  • Digital Pathology
By Application
  • Digestive Organs
  • Other
By Testing Services
  • Anatomic Pathology
  • Surgical Pathology
  • Cytopathology
  • Clinical Pathology

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Several Infectious Diseases Worldwide
      • 3.2.2. Rise in Incidence of Chronic Diseases
      • 3.2.3. Surge in Geriatric Population and Rise in Health Awareness
    • 3.3. Market Challenges
      • 3.3.1. Absence of Reimbursement Policies
    • 3.4. Market Trends
      • 3.4.1. Increasing Focus on Early Diagnosis of Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pathological Examination, by Type, Application, Testing Services and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Pathological Examination (Value)
      • 5.2.1. Global Pathological Examination by: Type (Value)
        • 5.2.1.1. Traditional Pathology
        • 5.2.1.2. Digital Pathology
      • 5.2.2. Global Pathological Examination by: Application (Value)
        • 5.2.2.1. Digestive Organs
        • 5.2.2.2. Other
      • 5.2.3. Global Pathological Examination by: Testing Services (Value)
        • 5.2.3.1. Anatomic Pathology
        • 5.2.3.2. Surgical Pathology
        • 5.2.3.3. Cytopathology
        • 5.2.3.4. Clinical Pathology
      • 5.2.4. Global Pathological Examination Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pathological Examination (Price)
      • 5.3.1. Global Pathological Examination by: Type (Price)
  • 6. Pathological Examination: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Quest Diagnostics, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sonic Healthcare Limited (Australia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Spectra Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Diagnostic Pathology Services, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Q2 Solutions (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Histo-Scientific Research Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Danaher Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Laboratory Corporation of America Holdings (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pathological Examination Sale, by Type, Application, Testing Services and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Pathological Examination (Value)
      • 7.2.1. Global Pathological Examination by: Type (Value)
        • 7.2.1.1. Traditional Pathology
        • 7.2.1.2. Digital Pathology
      • 7.2.2. Global Pathological Examination by: Application (Value)
        • 7.2.2.1. Digestive Organs
        • 7.2.2.2. Other
      • 7.2.3. Global Pathological Examination by: Testing Services (Value)
        • 7.2.3.1. Anatomic Pathology
        • 7.2.3.2. Surgical Pathology
        • 7.2.3.3. Cytopathology
        • 7.2.3.4. Clinical Pathology
      • 7.2.4. Global Pathological Examination Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pathological Examination (Price)
      • 7.3.1. Global Pathological Examination by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pathological Examination: by Type(USD Million)
  • Table 2. Pathological Examination Traditional Pathology , by Region USD Million (2018-2023)
  • Table 3. Pathological Examination Digital Pathology , by Region USD Million (2018-2023)
  • Table 4. Pathological Examination: by Application(USD Million)
  • Table 5. Pathological Examination Digestive Organs , by Region USD Million (2018-2023)
  • Table 6. Pathological Examination Other , by Region USD Million (2018-2023)
  • Table 7. Pathological Examination: by Testing Services(USD Million)
  • Table 8. Pathological Examination Anatomic Pathology , by Region USD Million (2018-2023)
  • Table 9. Pathological Examination Surgical Pathology , by Region USD Million (2018-2023)
  • Table 10. Pathological Examination Cytopathology , by Region USD Million (2018-2023)
  • Table 11. Pathological Examination Clinical Pathology , by Region USD Million (2018-2023)
  • Table 12. South America Pathological Examination, by Country USD Million (2018-2023)
  • Table 13. South America Pathological Examination, by Type USD Million (2018-2023)
  • Table 14. South America Pathological Examination, by Application USD Million (2018-2023)
  • Table 15. South America Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 16. Brazil Pathological Examination, by Type USD Million (2018-2023)
  • Table 17. Brazil Pathological Examination, by Application USD Million (2018-2023)
  • Table 18. Brazil Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 19. Argentina Pathological Examination, by Type USD Million (2018-2023)
  • Table 20. Argentina Pathological Examination, by Application USD Million (2018-2023)
  • Table 21. Argentina Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 22. Rest of South America Pathological Examination, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Pathological Examination, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 25. Asia Pacific Pathological Examination, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Pathological Examination, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Pathological Examination, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 29. China Pathological Examination, by Type USD Million (2018-2023)
  • Table 30. China Pathological Examination, by Application USD Million (2018-2023)
  • Table 31. China Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 32. Japan Pathological Examination, by Type USD Million (2018-2023)
  • Table 33. Japan Pathological Examination, by Application USD Million (2018-2023)
  • Table 34. Japan Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 35. India Pathological Examination, by Type USD Million (2018-2023)
  • Table 36. India Pathological Examination, by Application USD Million (2018-2023)
  • Table 37. India Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 38. South Korea Pathological Examination, by Type USD Million (2018-2023)
  • Table 39. South Korea Pathological Examination, by Application USD Million (2018-2023)
  • Table 40. South Korea Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 41. Taiwan Pathological Examination, by Type USD Million (2018-2023)
  • Table 42. Taiwan Pathological Examination, by Application USD Million (2018-2023)
  • Table 43. Taiwan Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 44. Australia Pathological Examination, by Type USD Million (2018-2023)
  • Table 45. Australia Pathological Examination, by Application USD Million (2018-2023)
  • Table 46. Australia Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Pathological Examination, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Pathological Examination, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 50. Europe Pathological Examination, by Country USD Million (2018-2023)
  • Table 51. Europe Pathological Examination, by Type USD Million (2018-2023)
  • Table 52. Europe Pathological Examination, by Application USD Million (2018-2023)
  • Table 53. Europe Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 54. Germany Pathological Examination, by Type USD Million (2018-2023)
  • Table 55. Germany Pathological Examination, by Application USD Million (2018-2023)
  • Table 56. Germany Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 57. France Pathological Examination, by Type USD Million (2018-2023)
  • Table 58. France Pathological Examination, by Application USD Million (2018-2023)
  • Table 59. France Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 60. Italy Pathological Examination, by Type USD Million (2018-2023)
  • Table 61. Italy Pathological Examination, by Application USD Million (2018-2023)
  • Table 62. Italy Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 63. United Kingdom Pathological Examination, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Pathological Examination, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 66. Netherlands Pathological Examination, by Type USD Million (2018-2023)
  • Table 67. Netherlands Pathological Examination, by Application USD Million (2018-2023)
  • Table 68. Netherlands Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 69. Rest of Europe Pathological Examination, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Pathological Examination, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 72. MEA Pathological Examination, by Country USD Million (2018-2023)
  • Table 73. MEA Pathological Examination, by Type USD Million (2018-2023)
  • Table 74. MEA Pathological Examination, by Application USD Million (2018-2023)
  • Table 75. MEA Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 76. Middle East Pathological Examination, by Type USD Million (2018-2023)
  • Table 77. Middle East Pathological Examination, by Application USD Million (2018-2023)
  • Table 78. Middle East Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 79. Africa Pathological Examination, by Type USD Million (2018-2023)
  • Table 80. Africa Pathological Examination, by Application USD Million (2018-2023)
  • Table 81. Africa Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 82. North America Pathological Examination, by Country USD Million (2018-2023)
  • Table 83. North America Pathological Examination, by Type USD Million (2018-2023)
  • Table 84. North America Pathological Examination, by Application USD Million (2018-2023)
  • Table 85. North America Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 86. United States Pathological Examination, by Type USD Million (2018-2023)
  • Table 87. United States Pathological Examination, by Application USD Million (2018-2023)
  • Table 88. United States Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 89. Canada Pathological Examination, by Type USD Million (2018-2023)
  • Table 90. Canada Pathological Examination, by Application USD Million (2018-2023)
  • Table 91. Canada Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 92. Mexico Pathological Examination, by Type USD Million (2018-2023)
  • Table 93. Mexico Pathological Examination, by Application USD Million (2018-2023)
  • Table 94. Mexico Pathological Examination, by Testing Services USD Million (2018-2023)
  • Table 95. Pathological Examination: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Pathological Examination: by Type(USD Million)
  • Table 107. Pathological Examination Traditional Pathology , by Region USD Million (2025-2030)
  • Table 108. Pathological Examination Digital Pathology , by Region USD Million (2025-2030)
  • Table 109. Pathological Examination: by Application(USD Million)
  • Table 110. Pathological Examination Digestive Organs , by Region USD Million (2025-2030)
  • Table 111. Pathological Examination Other , by Region USD Million (2025-2030)
  • Table 112. Pathological Examination: by Testing Services(USD Million)
  • Table 113. Pathological Examination Anatomic Pathology , by Region USD Million (2025-2030)
  • Table 114. Pathological Examination Surgical Pathology , by Region USD Million (2025-2030)
  • Table 115. Pathological Examination Cytopathology , by Region USD Million (2025-2030)
  • Table 116. Pathological Examination Clinical Pathology , by Region USD Million (2025-2030)
  • Table 117. South America Pathological Examination, by Country USD Million (2025-2030)
  • Table 118. South America Pathological Examination, by Type USD Million (2025-2030)
  • Table 119. South America Pathological Examination, by Application USD Million (2025-2030)
  • Table 120. South America Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 121. Brazil Pathological Examination, by Type USD Million (2025-2030)
  • Table 122. Brazil Pathological Examination, by Application USD Million (2025-2030)
  • Table 123. Brazil Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 124. Argentina Pathological Examination, by Type USD Million (2025-2030)
  • Table 125. Argentina Pathological Examination, by Application USD Million (2025-2030)
  • Table 126. Argentina Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 127. Rest of South America Pathological Examination, by Type USD Million (2025-2030)
  • Table 128. Rest of South America Pathological Examination, by Application USD Million (2025-2030)
  • Table 129. Rest of South America Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 130. Asia Pacific Pathological Examination, by Country USD Million (2025-2030)
  • Table 131. Asia Pacific Pathological Examination, by Type USD Million (2025-2030)
  • Table 132. Asia Pacific Pathological Examination, by Application USD Million (2025-2030)
  • Table 133. Asia Pacific Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 134. China Pathological Examination, by Type USD Million (2025-2030)
  • Table 135. China Pathological Examination, by Application USD Million (2025-2030)
  • Table 136. China Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 137. Japan Pathological Examination, by Type USD Million (2025-2030)
  • Table 138. Japan Pathological Examination, by Application USD Million (2025-2030)
  • Table 139. Japan Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 140. India Pathological Examination, by Type USD Million (2025-2030)
  • Table 141. India Pathological Examination, by Application USD Million (2025-2030)
  • Table 142. India Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 143. South Korea Pathological Examination, by Type USD Million (2025-2030)
  • Table 144. South Korea Pathological Examination, by Application USD Million (2025-2030)
  • Table 145. South Korea Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 146. Taiwan Pathological Examination, by Type USD Million (2025-2030)
  • Table 147. Taiwan Pathological Examination, by Application USD Million (2025-2030)
  • Table 148. Taiwan Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 149. Australia Pathological Examination, by Type USD Million (2025-2030)
  • Table 150. Australia Pathological Examination, by Application USD Million (2025-2030)
  • Table 151. Australia Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Pathological Examination, by Type USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Pathological Examination, by Application USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 155. Europe Pathological Examination, by Country USD Million (2025-2030)
  • Table 156. Europe Pathological Examination, by Type USD Million (2025-2030)
  • Table 157. Europe Pathological Examination, by Application USD Million (2025-2030)
  • Table 158. Europe Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 159. Germany Pathological Examination, by Type USD Million (2025-2030)
  • Table 160. Germany Pathological Examination, by Application USD Million (2025-2030)
  • Table 161. Germany Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 162. France Pathological Examination, by Type USD Million (2025-2030)
  • Table 163. France Pathological Examination, by Application USD Million (2025-2030)
  • Table 164. France Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 165. Italy Pathological Examination, by Type USD Million (2025-2030)
  • Table 166. Italy Pathological Examination, by Application USD Million (2025-2030)
  • Table 167. Italy Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 168. United Kingdom Pathological Examination, by Type USD Million (2025-2030)
  • Table 169. United Kingdom Pathological Examination, by Application USD Million (2025-2030)
  • Table 170. United Kingdom Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 171. Netherlands Pathological Examination, by Type USD Million (2025-2030)
  • Table 172. Netherlands Pathological Examination, by Application USD Million (2025-2030)
  • Table 173. Netherlands Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 174. Rest of Europe Pathological Examination, by Type USD Million (2025-2030)
  • Table 175. Rest of Europe Pathological Examination, by Application USD Million (2025-2030)
  • Table 176. Rest of Europe Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 177. MEA Pathological Examination, by Country USD Million (2025-2030)
  • Table 178. MEA Pathological Examination, by Type USD Million (2025-2030)
  • Table 179. MEA Pathological Examination, by Application USD Million (2025-2030)
  • Table 180. MEA Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 181. Middle East Pathological Examination, by Type USD Million (2025-2030)
  • Table 182. Middle East Pathological Examination, by Application USD Million (2025-2030)
  • Table 183. Middle East Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 184. Africa Pathological Examination, by Type USD Million (2025-2030)
  • Table 185. Africa Pathological Examination, by Application USD Million (2025-2030)
  • Table 186. Africa Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 187. North America Pathological Examination, by Country USD Million (2025-2030)
  • Table 188. North America Pathological Examination, by Type USD Million (2025-2030)
  • Table 189. North America Pathological Examination, by Application USD Million (2025-2030)
  • Table 190. North America Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 191. United States Pathological Examination, by Type USD Million (2025-2030)
  • Table 192. United States Pathological Examination, by Application USD Million (2025-2030)
  • Table 193. United States Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 194. Canada Pathological Examination, by Type USD Million (2025-2030)
  • Table 195. Canada Pathological Examination, by Application USD Million (2025-2030)
  • Table 196. Canada Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 197. Mexico Pathological Examination, by Type USD Million (2025-2030)
  • Table 198. Mexico Pathological Examination, by Application USD Million (2025-2030)
  • Table 199. Mexico Pathological Examination, by Testing Services USD Million (2025-2030)
  • Table 200. Pathological Examination: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pathological Examination: by Type USD Million (2018-2023)
  • Figure 5. Global Pathological Examination: by Application USD Million (2018-2023)
  • Figure 6. Global Pathological Examination: by Testing Services USD Million (2018-2023)
  • Figure 7. South America Pathological Examination Share (%), by Country
  • Figure 8. Asia Pacific Pathological Examination Share (%), by Country
  • Figure 9. Europe Pathological Examination Share (%), by Country
  • Figure 10. MEA Pathological Examination Share (%), by Country
  • Figure 11. North America Pathological Examination Share (%), by Country
  • Figure 12. Global Pathological Examination: by Type USD/Units (2018-2023)
  • Figure 13. Global Pathological Examination share by Players 2023 (%)
  • Figure 14. Global Pathological Examination share by Players (Top 3) 2023(%)
  • Figure 15. Global Pathological Examination share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Quest Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Quest Diagnostics, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Sonic Healthcare Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 20. Sonic Healthcare Limited (Australia) Revenue: by Geography 2023
  • Figure 21. Spectra Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Spectra Laboratories (United States) Revenue: by Geography 2023
  • Figure 23. Diagnostic Pathology Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Diagnostic Pathology Services, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Q2 Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 26. Q2 Solutions (United States) Revenue: by Geography 2023
  • Figure 27. Histo-Scientific Research Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Histo-Scientific Research Laboratories (United States) Revenue: by Geography 2023
  • Figure 29. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2023
  • Figure 31. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 33. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 36. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2023
  • Figure 37. Global Pathological Examination: by Type USD Million (2025-2030)
  • Figure 38. Global Pathological Examination: by Application USD Million (2025-2030)
  • Figure 39. Global Pathological Examination: by Testing Services USD Million (2025-2030)
  • Figure 40. South America Pathological Examination Share (%), by Country
  • Figure 41. Asia Pacific Pathological Examination Share (%), by Country
  • Figure 42. Europe Pathological Examination Share (%), by Country
  • Figure 43. MEA Pathological Examination Share (%), by Country
  • Figure 44. North America Pathological Examination Share (%), by Country
  • Figure 45. Global Pathological Examination: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Quest Diagnostics, Inc. (United States)
  • Sonic Healthcare Limited (Australia)
  • Spectra Laboratories (United States)
  • Diagnostic Pathology Services, Inc. (United States)
  • Q2 Solutions (United States)
  • Histo-Scientific Research Laboratories (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • Laboratory Corporation of America Holdings (United States)
Additional players considered in the study are as follows:
Agilent Technologies, Inc. (United States) , Biogenex Laboratories (United States) , Neogenomics Laboratories, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 213 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pathological Examination Market Quantitative research analysis
Global Pathological Examination Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Pathological Examination Market are Quest Diagnostics, Inc. (United States), Sonic Healthcare Limited (Australia), Spectra Laboratories (United States), Diagnostic Pathology Services, Inc. (United States), Q2 Solutions (United States), Histo-Scientific Research Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (United States), Thermo Fisher Scientific, Inc. (United States) and Laboratory Corporation of America Holdings (United States) etc.
Digestive Organs segment in Global market to hold robust market share owing to "Increase in Prevalence of Several Infectious Diseases Worldwide ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Pathological Examination market throughout the forecasted period.

Know More About Global Pathological Examination Market Report?

Have a Query? Click Here

Other Related Reports

HIV-AIDS Diagnostics Comprehensive Study by Type (Assay, Kit, Reagent, Instrument, Software, Services, Others), Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other...
$ 3350
Healthcare Contract Research Outsourcing Comprehensive Study by Service (Clinical Trial Service, Regulatory Service, Clinical Data Management & Biometrics, Medical Writing, Site Management Protocol, ...
$ 3750
Private Healthcare Comprehensive Study by Application (Hospitals, Pharmaceutical Industries, Medical Devices, Health Insurance, Medical Devices and Equipment, Others), Services (Curative, Preventive,...
$ 3350
Rickets Treatment Comprehensive Study by Type (Vitamin D-Related Rickets, Minerals Related Rickets), End User (Hospital, Clinics) Players and Region - Global Market Outlook to 2026
$ 3500
Small Joint Replacement Comprehensive Study by Type (Ankle Replacement, Digits Replacement, Elbow Replacement, Wrist Replacement), Application (Hospitals, Orthopedic Centers, Ambulatory Surgery Cente...
$ 3350
Medical Imaging Informatics Comprehensive Study by Type (Digital Radiography, Ultrasound, MRI, CT, Nuclear Imaging, Mammography), Energy Sources (Light, X-rays, Ultrasound, Nuclear Magnetic Resonance...
$ 3750